Navigation Links
Hip Replacement Patients at Possible Risk, Cleveland Law Firm Adds Zimmer Durom Cup Lawsuit Info on

Concern is mounting for thousands of hip replacement patients on the news of the Zimmer Durom® Cup Recall. The Cleveland Law Firm of Spangenberg Shibley & Liber has recently added news regarding these types of cases on their website The personal injury attorneys at SS&L said that they expect the number of lawsuits arising from the alleged defects in this acetabular cup component to grow, as more patients experience failures.

Cleveland, OH (PRWEB) January 15, 2009 -- "Lawrence Dorr, a nationally known orthopedic surgeon in Los Angeles, realized last year that something was very wrong with some of his patients. - The New York Times". After discovering an unexpected number of hip implant failures, Zimmer Inc. voluntarily recalled one of its artificial hip implants, the Zimmer Durom® Cup. Some of the patients who must now undergo expensive and painful revision surgery have filed product liability lawsuits. In light of this developing news the Cleveland Law Firm of Spangenberg Shibley & Liber has addressed this issue with new content on their website

Initially approved for market in March 2006, the company touted the Zimmer implant as superior for active patients since less bone removal was required than with conventional total hip arthroplasty (THA.) In late Fall 2007, however, Zimmer's foreign counterparts received reports that the product showed a "high amount of wear due to malpositioning of the cup after about one year." Notwithstanding this warning, the Durom® Cup continued to be marketed and implanted by surgeons in the United States who were unaware of the problems encountered in Europe.

In April 22, 2008, just two years after the implant was released into the U.S. market, a nationally recognized orthopedic surgeon, Larry Dorr, M.D. warned his colleagues within the American Association of Hip and Knee Surgeons of an unacceptably high failure rate. Specifically, he had found that 14 of the 165 Durom® hip cups implanted had required a revision surgery - a failure rate that far exceeded those of other available implants. Because the implants easily popped free during the revision surgeries, Dr. Dorr's team concluded that the patients' hip bone had been unable to incorporate the implant likely because of defects in the cup's design and surface coating.

In response to Dr. Dorr's warning, Zimmer informed surgeons that it was internally investigating the complaints. In an apparent attempt to reassure surgeons of the implant's safety, Zimmer cited to its own clinical trials and international experience dating back to 2003. Within the same letter, however, Zimmer acknowledged that the U.S. version of the implant was not identical to the European version.

Following Dr. Dorr's warning and Zimmer's response, the Food and Drug Administration received several 'adverse event reports' concerning this possible defective medical device. Under mounting pressure, on July 22, 2008, Zimmer temporarily suspended marketing in the U.S. or voluntarily recalled the device. In what appeared to be an attempt to blame the implanting surgeons' technique, Zimmer claimed that 'revised surgical technical instructions and a surgical training program' were required 'to achieve desired clinical results in the U.S.' In an apparent about-face, however, Zimmer later told at least some of the patients requiring revision surgery that it did 'not fault' the surgeons and was 'taking the responsibility for corrective action.'

Despite Zimmer's purported commitment to take 'corrective action,' several patients have formally filed Zimmer Durom® cup lawsuits alleging defects in the implant. These numbers are expected to climb as more patients experience failures and are advised of their legal rights. Personal injury attorneys and law firms, like Rhonda Baker Debevec, Esq. and Nicholas A. DiCello, Esq. of the Cleveland, Ohio firm Spangenberg Shibley and Liber Law Firm, are investigating potential claims on behalf of the estimated 12,000 patients implanted with the device.    

About Spangenberg, Shibley & Liber LLP:

Spangenberg, Shibley & Liber LLP is a Cleveland Law Firm that manages cases of wrongful death, personal injury, malpractice, negligence, and injuries to classes of consumers involving defective drugs, medical devices and product liability for consumer products. The firm also manages business disputes and prosecutes insurance claims on behalf of businesses and individuals. For more than 60 years, the Spangenberg law firm has devoted itself to representing injured persons and aggrieved businesses. Spangenberg, Shibley & Liber LLP is headquartered in Cleveland, Ohio, at 1900 East Ninth Street, Suite 2400. For more information we invite you to visit

Rhonda Baker Debevec, Esq.
Spangenberg Shibley & Liber Law Firm
1900 East Ninth Street, Suite 2400
Cleveland, Ohio 44114
Telephone: (216) 696-3232 EXT. 109
Facsimile: (216) 696-3924

Nicholas A. DiCello, Esq.
Spangenberg Shibley & Liber Law Firm
1900 East Ninth Street, Suite 2400
Cleveland, Ohio 44114
Telephone: (216) 696-3232 EXT. 172
Facsimile: (216) 696-3924


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Replacing Your Total Hip Replacement
2. Surgeons Often Are Blamed When Hip Replacements Fail
3. Multiple ICD Replacements Can Predict Complications
4. November 2008 Mayo Clinic Womens HealthSource Highlights 10 Symptoms Not To Ignore, Knee Replacements and Nonprescription Weight-Loss Pills
5. Wait time guarantees not likely to reduce waits for joint replacement surgery
6. Pioneer(R) Surgical Technologys NuBac(R) Nucleus Replacement Device Wins FDA Approval for IDE Pivotal Study
7. Successive Births, HRT Use Boost Joint Replacement Risks
8. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
9. Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
10. Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
11. Re: Replacement of a Trustee for the Holders of Series A, Series B and Series C Notes of Elbit Imaging Ltd. (the "Company")
Post Your Comments:
Related Image:
Hip Replacement Patients at Possible Risk, Cleveland Law Firm Adds Zimmer Durom Cup Lawsuit Info on
(Date:6/27/2016)... ... , ... recently awarded their highest five-star rating to Best Buy Eyeglasses, ... the United States and Canada wear eyeglasses. Once considered to be a purely functional ... a fashion statement. Even celebrities use glasses as a way of creating an iconic ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users ... - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 ... Pro X . Simply select a ProHand generator and drag it above media or ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of ... of the latter, setting the bar too high can result in disappointment, perhaps even ... progress toward their goal. , Research from reveals that behind ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology: